Figure 1.
MRI imaging of brain metastasis. MRI imaging from a male patient (patient no. 3, Tables I and II). The cranial tumor exhibited a partial response (PR) after receiving one cycle of erlotinib plus pemetrexed/cisplatin. Left panel, prior to treatment. Right panel, image after one treatment cycle. MRI, magnetic resonance imaging.